XDG3.DE vs. CURE.DE
XDG3.DE (Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C) and CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) are both Health & Biotech Equities funds - XDG3.DE tracks the MSCI ACWI IMI SDG 3 Good Health and Well-being Select while CURE.DE tracks the MVIS Global Future Healthcare ESG. Both are passively managed. Over the past 3 years, XDG3.DE returned 1.94%/yr vs -2.48%/yr for CURE.DE. A 0.61 correlation means they provide meaningful diversification when combined. Both charge a 0.35% expense ratio.
Performance
XDG3.DE vs. CURE.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XDG3.DE achieves a -6.02% return, which is significantly lower than CURE.DE's -5.10% return.
XDG3.DE
- 1D
- 2.88%
- 1M
- 2.53%
- YTD
- -6.02%
- 6M
- -6.54%
- 1Y
- 2.67%
- 3Y*
- 1.94%
- 5Y*
- —
- 10Y*
- —
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
XDG3.DE vs. CURE.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
XDG3.DE Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | -6.02% | 1.47% | 9.58% | 2.52% |
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -7.74% |
Correlation
The correlation between XDG3.DE and CURE.DE is 0.68, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.68 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.61 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2023 | 0.61 |
The correlation between XDG3.DE and CURE.DE has been stable across timeframes, ranging from 0.61 to 0.68 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XDG3.DE vs. CURE.DE — Risk / Return Rank
XDG3.DE
CURE.DE
XDG3.DE vs. CURE.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) and VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XDG3.DE | CURE.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.13 | ||
| Sortino ratioReturn per unit of downside risk | -0.21 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.06 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 0.17 | 0.30 | -0.13 |
| Martin ratioReturn relative to average drawdown | 0.44 | 0.68 | -0.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XDG3.DE | CURE.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.16 | 0.29 | -0.13 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.16 | -0.14 | +0.30 |
Drawdowns
XDG3.DE vs. CURE.DE - Drawdown Comparison
The maximum XDG3.DE drawdown since its inception was -20.49%, smaller than the maximum CURE.DE drawdown of -34.80%. Use the drawdown chart below to compare losses from any high point for XDG3.DE and CURE.DE.
Loading charts...
Drawdown Indicators
| XDG3.DE | CURE.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -20.49% | -34.80% | +14.31% |
Max Drawdown (1Y)Largest decline over 1 year | -13.31% | -19.07% | +5.76% |
Max Drawdown (3Y)Largest decline over 3 years | -20.49% | -29.32% | +8.83% |
Current DrawdownCurrent decline from peak | -11.91% | -15.66% | +3.75% |
Average DrawdownAverage peak-to-trough decline | -5.57% | -15.12% | +9.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.29% | 8.53% | -3.24% |
Volatility
XDG3.DE vs. CURE.DE - Volatility Comparison
The current volatility for Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C (XDG3.DE) is 4.95%, while VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a volatility of 5.73%. This indicates that XDG3.DE experiences smaller price fluctuations and is considered to be less risky than CURE.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XDG3.DE | CURE.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.95% | 5.73% | -0.78% |
Volatility (6M)Calculated over the trailing 6-month period | 10.56% | 15.20% | -4.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.57% | 19.97% | -5.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.31% | 20.74% | -7.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 13.31% | 20.74% | -7.43% |
XDG3.DE vs. CURE.DE - Expense Ratio Comparison
Both XDG3.DE and CURE.DE have an expense ratio of 0.35%.
Dividends
XDG3.DE vs. CURE.DE - Dividend Comparison
Neither XDG3.DE nor CURE.DE has paid dividends to shareholders.
Frequently Asked Questions
XDG3.DE and CURE.DE have a correlation of 0.68, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
XDG3.DE and CURE.DE have the same expense ratio: 0.35% per year.
XDG3.DE tracks MSCI ACWI IMI SDG 3 Good Health and Well-being Select, while CURE.DE tracks MVIS Global Future Healthcare ESG. They also come from different issuers: Xtrackers and VanEck.
Find the right allocation for XDG3.DE and CURE.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer